CD80
CD86
CD28
受体
生物
T细胞
CTLA-4号机组
细胞生物学
分子生物学
CD40
免疫系统
免疫学
细胞毒性T细胞
生物化学
体外
作者
P S Linsley,JoAnne L. Greene,William Brady,Jürgen Bajorath,J A Ledbetter,Robert Peach
出处
期刊:Immunity
[Elsevier]
日期:1994-12-01
卷期号:1 (9): 793-801
被引量:950
标识
DOI:10.1016/s1074-7613(94)80021-9
摘要
B7-0 or B7-2 (CD86) is a T cell costimulatory molecule that binds the same receptors (CD28 and CTLA-4) as B7-1 (CD80), but shares with it only approximately 25% sequence identity and is expressed earlier during an immune response. Here we show that human CD86 maintains similar (within approximately 2- to 3-fold) overall receptor binding and T cell costimulatory properties as CD80. However, CD80 and CD86 did not bind equivalently to CTLA-4: CD80 bound Y100A, a form of CTLA4lg with a mutation in the CDR3-like region, > 200-fold better than did CD86; inhibition of CD80-mediated cellular responses required approximately 100-fold lower CTLA4lg concentrations; and CD80-CTLA4lg complexes dissociated 5- to 8-fold more slowly, Thus, CD80 and CD86 utilize different binding determinants and have different kinetics of binding to CD28 and CTLA-4.
科研通智能强力驱动
Strongly Powered by AbleSci AI